SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000320017-24-000051
Filing Date
2024-08-12
Accepted
2024-08-12 16:21:38
Documents
80
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lsta-20240630.htm   iXBRL 10-Q 952556
2 EX-31.1 lsta-ex311_20240630.htm EX-31.1 9599
3 EX-31.2 lsta-ex312_20240630.htm EX-31.2 9641
4 EX-32.1 lsta-ex321_20240630.htm EX-32.1 6844
5 EX-32.2 lsta-ex322_20240630.htm EX-32.2 6926
11 lsta-20240630_g1.jpg GRAPHIC 182599
  Complete submission text file 0000320017-24-000051.txt   6554818

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lsta-20240630.xsd EX-101.SCH 46441
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lsta-20240630_cal.xml EX-101.CAL 58976
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lsta-20240630_def.xml EX-101.DEF 179295
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lsta-20240630_lab.xml EX-101.LAB 639932
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lsta-20240630_pre.xml EX-101.PRE 428137
83 EXTRACTED XBRL INSTANCE DOCUMENT lsta-20240630_htm.xml XML 743957
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33650 | Film No.: 241197090
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)